Literature DB >> 26974703

In vivo and in vitro evaluation of hydroxyapatite nanoparticle morphology on the acute inflammatory response.

Shiuli Pujari-Palmer1, Song Chen1, Stefano Rubino2, Hong Weng3, Wei Xia1, Håkan Engqvist1, Liping Tang3, Marjam Karlsson Ott4.   

Abstract

Biomedical implants have been widely used in bone repair applications. However, nanosized degradation products from these implants could elicit an inflammatory reaction, which may lead to implant failure. It is well known that the size, chemistry, and charge of these nanoparticles can modulate this response, but little is known regarding the role that the particle's morphology plays in inducing inflammation. The present study aims to investigate the effect of hydroxyapatite nanoparticle (HANPs) morphology on inflammation, in-vitro and in-vivo. Four distinct HANP morphologies were fabricated and characterized: long rods, dots, sheets, and fibers. Primary human polymorphonuclear cells (PMNCs), mononuclear cells (MNCs), and human dermal fibroblasts (hDFs) were exposed to HANPs and alterations in cell viability, morphology, apoptotic activity, and reactive oxygen species (ROS) production were evaluated, in vitro. PMNCs and hDFs experienced a 2-fold decrease in viability following exposure to fibers, while MNC viability decreased 5-fold after treatment with the dots. Additionally, the fibers stimulated an elevated ROS response in both PMNCs and MNCs, and the largest apoptotic behavior for all cell types. Furthermore, exposure to fibers and dots resulted in greater capsule thickness when implanted subcutaneously in mice. Collectively, these results suggest that nanoparticle morphology can significantly impact the inflammatory response.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hydroxyapatite nanoparticles; In vivo; Mononuclear cells; Morphology; Polymorphonuclear cells; Reactive oxygen species

Mesh:

Substances:

Year:  2016        PMID: 26974703     DOI: 10.1016/j.biomaterials.2016.02.039

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Evaluating the Apoptotic Cell Death Modulatory Activity of Nanoparticles in Men and Women Neutrophils and Eosinophils.

Authors:  Marion Vanharen; Isabelle Durocher; Abdelaziz Saafane; Denis Girard
Journal:  Inflammation       Date:  2021-09-18       Impact factor: 4.092

2.  Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles.

Authors:  Maria-Argyro Karageorgou; Dimosthenis Stamopoulos
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

3.  The Influence of Hydroxyapatite Nanoparticle Morphology on Embryonic Development in a Zebrafish Exposure Model.

Authors:  Shiuli Pujari-Palmer; Xi Lu; Marjam Karlsson Ott
Journal:  Nanomaterials (Basel)       Date:  2017-04-22       Impact factor: 5.076

Review 4.  The Hemocompatibility of Nanoparticles: A Review of Cell-Nanoparticle Interactions and Hemostasis.

Authors:  Kara M de la Harpe; Pierre P D Kondiah; Yahya E Choonara; Thashree Marimuthu; Lisa C du Toit; Viness Pillay
Journal:  Cells       Date:  2019-10-07       Impact factor: 6.600

5.  Addressing the Osteoporosis Problem-Multifunctional Injectable Hybrid Materials for Controlling Local Bone Tissue Remodeling.

Authors:  Adriana Gilarska; Alicja Hinz; Monika Bzowska; Grzegorz Dyduch; Kamil Kamiński; Maria Nowakowska; Joanna Lewandowska-Łańcucka
Journal:  ACS Appl Mater Interfaces       Date:  2021-10-13       Impact factor: 9.229

6.  Hydroxyapatite nanoparticles drive the potency of Toll-like receptor 9 agonist for amplified innate and adaptive immune response.

Authors:  Qin Zeng; Ruiqi Wang; Yuchen Hua; Hongfeng Wu; Xuening Chen; You-Cai Xiao; Qiang Ao; Xiangdong Zhu; Xingdong Zhang
Journal:  Nano Res       Date:  2022-07-23       Impact factor: 10.269

7.  Biomimetic anti-inflammatory and osteogenic nanoparticles self-assembled with mineral ions and tannic acid for tissue engineering.

Authors:  Hayeon Byun; Gyu Nam Jang; Min-Ho Hong; Jiwon Yeo; Hyunjung Shin; Won Jong Kim; Heungsoo Shin
Journal:  Nano Converg       Date:  2022-10-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.